Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase EARLY_PHASE1 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

NET 2Endocrine 2CNS 2

Conditions

Neuroendocrine Tumors 3Paraganglioma 2Neuroblastoma 2Carcinoid Tumor 2Tumor Positron-Emission Tomography 1Pheochromocytoma 1Meningioma 1Medulloblastoma 1

Interventions

gallium Ga 68 dotatate 2surufatinib 1olaparib 1lutetium Lu 177 dotatate 1TKM-080301 1Magnetic Resonance Spectroscopy 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Carcinoid Tumor × gallium Ga 68 dotatate × Clear all
NCT01619865 2021-07-27

GA-68

University of Iowa

Phase 1/2 Completed
223 enrolled 11 charts
CNSEndocrineNET

Carcinoid Tumor, Medulloblastoma, Neuroblastoma, Neuroendocrine Tumors

NCT02177773 2019-11-12

DOTA-TOC

University of California, San Francisco

Phase 1/2 Terminated
300 enrolled 5 charts
CNSEndocrineNET

Carcinoid Tumor, Neuroblastoma, Paraganglioma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡